UNSPSC 51102837: Ciprofloxacin/hydrocortisone

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT250. This VA Drug Class (OT250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OTIC.

UNSPSC 51102837 Ciprofloxacin/hydrocortisone is a Commodity code covering pharmaceutical products, specifically ciprofloxacin-based medications and related antimicrobial and anti-inflammatory formulations that state and local health departments procure for public health supply chains and emergency response stockpiles. State and local health agencies—including state departments of public health and county health departments—are the primary issuing bodies under this code, typically sourcing through competitive bidding processes that leverage cooperative purchasing consortiums and piggyback contracting vehicles to achieve volume pricing and streamlined procurement.

Recent activity centers on the Illinois Department of Public Health's award through the MMCAP Infuse cooperative purchasing consortium, which procured ciprofloxacin hydrochloride 500mg tablets in bulk pharmaceutical packages under an IFB process completed August 28, 2026, with a total contract value of $2,999,999.11 across a 12-month initial term and two optional renewal years. While Seminole County, Florida posted a separate health-supplies RFQ in June 2026 for naloxone and drug deactivation systems (a closely related emergency pharmaceutical procurement), it was directed to a different UNSPSC code. Illinois and Florida represent the visible geographic footprint in recent postings; the code shows limited open-market activity, with most volume moving through cooperative purchasing awards rather than independently issued solicitations.